Other cancers

Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Ferri GM, Martinez CB, Acevedo J, …, Szalat RE, Sloan JM

Breast Cancer Research and Treatment215(1)DOI: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitorsPubMed: Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study

Fillmore NR, La J, Szalat RE, …, Munshi NC

JNCI: Journal of the National Cancer Institute113(6):691-698DOI: Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs StudyPubMed: Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study

Functional profiling of nucleotide Excision repair in breast cancer

Rajkumar-Calkins AS, Szalat R, Dreze M, …, Mouw KW

DNA Repair82:102697DOI: Functional profiling of nucleotide Excision repair in breast cancerPubMed: Functional profiling of nucleotide Excision repair in breast cancer

Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide

AlGain M, Damade R, Aucouturier F, …, Szalat R, …, Bouaziz JD

Journal of the European Academy of Dermatology and Venereology31(1)DOI: Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamidePubMed: Catastrophic cryofibrinogenaemia associated with chronic lymphocytic leukaemia and salvage therapy using plasmapheresis and cyclophosphamide

Non-random patterns of multiple primary malignancies in the era of cancer survival.

George T, Nannini K, Bihn JR, Samur MK, Szalat RE, DuMontier C, Fillmore N, Munshi NC

Journal of Clinical Oncology44(16_suppl):10584-10584DOI: Non-random patterns of multiple primary malignancies in the era of cancer survival.

Effect of duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors

Ferri G, Beiner Martinez C, Acevedo J, Bhatt S, Verma K, Abdallah M, Szalat R, Sloan JM

Blood146(Supplement 1):6170-6170DOI: Effect of duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors